Author:
Lichtenstein Kenneth,Balasubramanyam Ashok,Sekhar Rajagopal,Freedland Eric
Abstract
Abstract
Human immunodeficiency virus (HIV)-associated adipose redistribution syndrome (HARS) is a fat accumulation disorder characterized by increases in visceral adipose tissue. Patients with HARS may also present with excess truncal fat and accumulation of dorsocervical fat ("buffalo hump"). The pathophysiology of HARS appears multifactorial and is not fully understood at present. Key pathophysiological influences include adipocyte dysfunction and an excessive free fatty acid release by adipocyte lipolysis. The contributory roles of free fatty acids, cytokines, hormones including cortisol, insulin and the growth hormone-adipocyte axis are significant. Other potential humoral, paracrine, endocrine, and neural influences are also discussed.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Virology,Molecular Medicine
Reference53 articles.
1. Garcia-Viejo MA, Ruiz M, Martinez E: Strategies for treating HIV-related lipodystrophy. Expert Opin Investig Drugs. 2001, 10 (8): 1443-1456. 10.1517/13543784.10.8.1443
2. Powderly WG: Long-term exposure to lifelong therapies. J Acquir Immune Defic Syndr. 2002, 29 Suppl 1: S28-40.
3. Carr A, Emery S, Law M, Puls R, Lundgren JD, Powderly WG: An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet. 2003, 361 (9359): 726-735. 10.1016/S0140-6736(03)12656-6
4. Sattler F: Body habitus changes related to lipodystrophy. Clin Infect Dis. 2003, 36 (Suppl 2): S84-90. 10.1086/367563.
5. DP K: Estimated Prevalence of HIV-associated adipose redistribution syndrome (HARS) - abnormal abdominal fat accumulation - in HIV-infected patients. Antivir Ther. 2004, 9 (6): L33 -Washington, DC,
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献